title: Atorvastatin versus revascularization treatment (AVERT): fact or fancy?
authors.forename: B M
authors.initials: BM
authors.lastname: Singh
authors.forename: S
authors.initials: S
authors.lastname: Puri
authors.forename: J
authors.initials: J
authors.lastname: Saucedo
authors.forename: J D
authors.initials: JD
authors.lastname: Talley
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy* / Q000601:surgery*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods*; D018579:Patient Selection; D011758:Pyrroles / Q000627:therapeutic use*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin